HIV Mutation Detail Information

> M184I Search Result


Mutation Information
Mutation Site M184I
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Relevant Drug abacavir (ABC);didanosine (DDI);emtricitabine (FTC);emtricitabine (FTC);lamivudine (LAM);efavirenz (EFV);etravirine(ETR);nevirapine (NPV);rilpivirine (RPV)
Country India
Literature Information
PubMed PMID 30315192
Disease HIV infection/AIDS
Published Year 2018
Journal Scientific reports
Title Antiretroviral resistance, genotypic characterization and origin of Human Immunodeficiency Virus among the infected wives of Intravenous drug users in Manipur.
Author Sharma AL,Singh TR,Singh LS
Evidence The common DRMs found among the ART treatment experienced individuals were targeted at (i) NRTI positions: M184V (10%, 3/30), M184I (6.7%, 2/30) and M41L, D67N, T69D, K70G/R, Y115F, T215N and K219R/Q (3.3% each, 1/30) (ii) NNRTI positions: A98G, K103N, V179D/E, Y181C, G190A/R (6.7% each, 2/30), K101E, V106A/M, V108I, Y181F, H221Y and M230I (3.3% each, 1/30) and (iii) protease inhibitors positions: major mutation M46L (3.3%, 1/30) and other mutations L24I, G48K and G73S (3.3% each, 1/30).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation